USA - engelsk - NLM (National Library of Medicine)

dava pharmaceuticals inc - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil anhydrous 250 mg - cefprozil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. caused by streptococcus pneumoniae, haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including β-lactamase-producing strains). (see clinical studies .) note: in the treatment of otitis media due to β-lactamase-producing organisms, cefprozil had bacteriologic eradication rates somewhat lower than those observed with a

USA - engelsk - NLM (National Library of Medicine)

sandoz inc - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil anhydrous 250 mg - cefprozil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. caused by streptococcus pneumoniae, haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including β-lactamase-producing strains). (see clinical studies .) note: in the treatment of otitis media due to β-lactamase-producing organisms, cefprozil had bacteriologic eradication rates somewhat lower than those observed with a

USA - engelsk - NLM (National Library of Medicine)

wockhardt limited - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil anhydrous 250 mg - cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: pharyngitis/tonsillitis caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. otitis media caused by streptococcus pneumoniae, haemophilus influenzae (including β-lactamase-producing strains), and moraxella  (branhamella) catarrhalis (including β-lactamase-producing strains). (see clinical studies .) note: in the treatment of otitis media due to β-lactamase producing organisms, cefprozil had bacteriologic eradicatio

USA - engelsk - NLM (National Library of Medicine)

wockhardt usa llc. - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil anhydrous 250 mg - cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: pharyngitis/tonsillitis caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. otitis media caused by streptococcus pneumoniae,  haemophilus influenzae (including β-lactamase-producing strains), and moraxella  (branhamella) catarrhalis (including β-lactamase-producing strains). (see clinical studies .) note: in the treatment of otitis media due to β-lactamase producing organisms, cefprozil had bacteriologic eradicati

Canada - fransk - Health Canada

apotex inc - cefprozil (monohydrate de cefprozil) - comprimé - 250mg - cefprozil (monohydrate de cefprozil) 250mg - second generation cephalosporins

Canada - fransk - Health Canada

apotex inc - cefprozil (monohydrate de cefprozil) - comprimé - 500mg - cefprozil (monohydrate de cefprozil) 500mg - second generation cephalosporins

Canada - engelsk - Health Canada

apotex inc - cefprozil (cefprozil monohydrate) - tablet - 250mg - cefprozil (cefprozil monohydrate) 250mg - second generation cephalosporins

Canada - engelsk - Health Canada

apotex inc - cefprozil (cefprozil monohydrate) - tablet - 500mg - cefprozil (cefprozil monohydrate) 500mg - second generation cephalosporins

USA - engelsk - NLM (National Library of Medicine)

orchidpharma inc - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil anhydrous 125 mg in 5 ml - cefprozil for oral suspension is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: upper respiratory tract pharyngitis/tonsillitis caused by streptococcus pyogenes. note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil for oral suspension is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil for oral suspension in the subsequent prevention of rheumatic fever are not available at present. otitis media caused by streptococcus pneumoniae, haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella ) catarrhalis (including β-lactamase-producing strains). (see clinical studies. ) note: in the treatment of otitis media due

USA - engelsk - NLM (National Library of Medicine)

h. j. harkins company, inc. - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil anhydrous 500 mg - cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. caused by streptococcus pneumoniae, haemophilus influenzae (including ß-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including ß-lactamase-producing strains). (see clinical studies.) note: in the treatment of otitis media due to ß-lactamase producing organisms, cefprozil had bacteriologic eradication rates somewhat lower than those observe